- ¥2020
- BIO-RAD
- PBP036
- 进口
- 2026年02月01日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
现货
- 英文名：
RECOMBINANT BOVINE LEUKEMIA INHIBITORY FACTOR
- 供应商：
上海善然生物科技有限公司
- 保存条件：
低温
- 规格：
1EA
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Acute myeloid leukemia (AML) has an annual incidence of 2.4 cases per 100,000 persons and is the most common form of acute leukemia in adults (1 , 2 ). AML is a model for drug-resistant human cancers, and current therapies for AML possess
Nijmegen-Bethesda Assay to Measure Factor VIII Inhibitors
Hemophilia A is an inherited bleeding disorder caused by a deficiency of factor VIII coagulant activity (FVIII:C). Patients are treated with infusions of either plasma-derived or recombinant factor VIII. However, some patients develop
Dynamic Monitoring of Cellular Remodeling Induced by the Transforming Growth Factor-β1
epithelial cells with the transforming growth factor-β1. Changes in the cell index profile were paralleled with cytoskeleton rebuilding and induction of epithelial�mesenchymal transition and negatively correlated with cell proliferation. This novel
技术资料暂无技术资料 索取技术资料
